The race to produce a herpes virus vaccine heated up today with the announcement of a second mRNA-based clinical trial commencing.
Biopharmaceutical New Technologies (BioNTech) SE, a global leader in mRNA vaccines, announced that the first subject was dosed in a Phase 1 clinical research study with BNT163, a herpes simplex virus (HSV) vaccine candidate for the prevention of genital lesions caused by HSV-2 and potentially HSV-1.
Another mRNA Herpes Vaccine Candidate Launches
When Are Airports Busy in 2022
The Transportation Security Administration (TSA) recently answered a leading question most air travelers ask when preparing to travel over the 2022 holiday season.
The TSA announced that it expects travel volumes to be busiest on Dec. 22 and Dec. 30, 2022.
Additionally, the TSA suggests packing an extra dose of patience on those days!
As of December 20, 2022, TSA airport activity approached about 95% of 2019 volumes.
U.S. to Release Flu Meds From National Stockpile to Ease Shortages
Decision comes as the nation suffers from an unusually early and hard flu season, with about 9,300 deaths so far
Bivalent COVID-19 mRNA Booster Effective
Bivalent booster is effective against COVID-19 hospitalization in immunocompetent adults, seniors
2001 to 2021 Saw Decline in Physician Work Hours
However, trend offset by increase in advanced practice professionals weekly work hours
New Ebola Vaccines Aspire to Achieve Older Version Success
As the current Sudan Ebolavirus outbreak in the Republic of Uganda comes to a close, researchers are scrambling to conduct clinical trials to determine if a new set of vaccine candidates can match the efficacy found in previous Ebola vaccines.
An Original Article recently published in the peer-reviewed New England Journal of Medicine (NEJM) confirmed that two existing Ebola vaccines trigger durable immune responses, with antibodies detectable a year after the first dose administration.
Texas Testing Empowers Sudan Ebolavirus Vaccine and Therapeutic Development
While there are approved vaccines and therapies for one type of Ebola virus, a recent outbreak in Africa has highlighted the need for additional innovations.
Since the current Sudan ebolavirus (SUDV) outbreak began in September 2022, at least 142 people have been infected, and 55 people have died, including children and healthcare workers.
In Face of Tripledemic, CVS and Walgreens Limit Purchases of Pediatric Pain Meds
Medication limits are meant to ‘ensure equitable access,’ according to a CVS statement
Coinfection With Flu, SARS-CoV-2 Described in Children
SARS-CoV-2 coinfection occurred in 6 percent of pediatric influenza-associated hospitalizations
Nursing Care Shortages Likely to Have Predated Pandemic
No evidence that large numbers of nurses left health care or hospital practice during first 18 months of pandemic